Front Row Advisors LLC Bio Rad Laboratories, Inc. Transaction History

Front Row Advisors LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$268.26 - $339.48 $536 - $678	-2 Reduced 10.0%	18 $4,000
Q1 2024 May 14, 2024	BUY	$304.11 - $351.99 $6,082 - $7,039	20 New	20 $6,000
Q2 2023 Aug 14, 2023	BUY	$359.49 - $486.4 $1,437 - $1,945	4 Added 30.77%	17 $6,000
Q1 2023 May 22, 2023	BUY	$418.69 - $503.0 $2,930 - $3,521	7 Added 116.67%	13 $6,000
Q1 2023 May 15, 2023	SELL	$418.69 - $503.0 $3,349 - $4,024	-8 Reduced 57.14%	6 $1,000
Q4 2022 Feb 15, 2023	BUY	$351.71 - $456.01 $1,758 - $2,280	5 Added 55.56%	14 $6,000
Q2 2022 Aug 15, 2022	BUY	$463.67 - $597.16 $463 - $597	1 Added 12.5%	9 $4,000
Q1 2022 May 11, 2022	SELL	$524.57 - $735.42 $2,098 - $2,941	-4 Reduced 33.33%	8 $4,000
Q4 2021 Mar 09, 2022	SELL	$708.84 - $794.68 $1,417 - $1,589	-2 Reduced 14.29%	12 $9,000
Q1 2021 Apr 28, 2021	BUY	$547.01 - $662.35 $547 - $662	1 Added 7.69%	14 $8,000
Q3 2020 Nov 30, 2020	SELL	$454.43 - $535.6 $1,817 - $2,142	-4 Reduced 23.53%	13 $7,000
Q1 2020 May 08, 2020	SELL	$320.01 - $409.07 $640 - $818	-2 Reduced 10.53%	17 $7,000
Q3 2019 Nov 08, 2019	BUY	$304.55 - $345.24 $1,218 - $1,380	4 Added 26.67%	19 $6,000
Q3 2018 Nov 13, 2018	BUY	$289.28 - $326.15 $4,339 - $4,892	15 New	15 $4,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Front Row Advisors LLC with notifications on news.